Clinical Trial: ADJUnct Semaglutide Treatment in Type 1 Diabetes
Study Status: Completed
Recruit Status: RECRUITING
Condition: Type 1 Diabetes
Study Type: INTERVENTIONAL
Official Title: Efficacy and Safety of Once Weekly Semaglutide in Adults With Obesity and Inadequately Controlled Type 1 Diabetes Using Hybrid Closed-Loop System.
Brief Summary:
The purpose of this study is to assess the use of once weekly semaglutide injection in inadequately controlled obese adults with type 1 diabetes (T1D) using FDA-approved hybrid closed-loop therapies.
Read more